Midgard Science

Clarenta

Sofia, Bulgaria clarenta.com From their website, Nov 2026

Work here? Claim this listing

About

Clarenta is a European contract research organization supporting biotech and pharmaceutical companies through non-clinical development, CMC development, early-phase clinical research and full-service clinical trial delivery. It works with sponsors across Europe and has an early-phase unit in Sofia, with non-clinical and regulatory expertise also based in France through Leads To Development. The group says it supports clinical development across 24 countries.

Services

  • Clinical Research Consulting

    Advises on development strategy, non-clinical inputs, regulatory strategy, trial design and clinical operations before a protocol is written.

  • Full-service CRO

    Plans and delivers clinical trials across Europe, including clinical operations, project management, regulatory affairs, medical oversight, data management, biostatistics and pharmacovigilance.

  • Phase I Unit

    Supports early clinical studies in healthy volunteers and patients from an on-site unit in Sofia with an on-site pharmacy and clinical laboratory.

  • Strategic Non-clinical Planning

    Builds a non-clinical development plan covering study sequence, regulatory steps, manufacturing requirements and gaps to clinical milestones.

  • Non-clinical Development

    Selects and manages GLP-compliant CROs, reviews protocols and reports, audits service providers and coordinates toxicology and pharmacology studies.

  • CMC Development

    Plans chemistry, manufacturing and control work including process development, scale-up, analytical methods, formulation, stability and GMP or non-GMP manufacturing.

  • Early-stage Regulatory Affairs

    Supports early regulatory strategy, scientific advice, pre-IND meetings, orphan drug or fast-track designations, CTA or IND applications and agency responses.

  • Early Phase Clinical Development

    Supports early clinical development from first-in-human studies through proof-of-concept and PK/clinical pharmacology studies.

4 more services
  • Early Phase Oncology Trials
  • First-in-Human (FIH) Studies
  • Proof-of-Concept (PoC) Studies
  • PK & Clinical Pharmacology Studies
Turnaround
  • 36 patients enrolled within approximately two months
  • 48 participants enrolled
What to send
  • Sample collection and processing
  • Bioanalytical assay readiness

Capabilities

Assays and studies
  • Bioanalysis
  • Pharmacokinetic sampling
  • Bioanalytical assays
  • Safety assessments
  • Tolerability assessments
  • Pharmacodynamic assessments
5 more
  • Biomarker assessments
  • Clinical monitoring
  • Analytical testing
  • Potency assays
  • Bioanalytical methods
Scale and capacity
  • 1 Phase I unit
  • 24 countries covered
Therapeutic areas
  • Oncology
  • Onco-haematology
  • Rare diseases
  • Neurology
  • Psychiatry
  • Immunology
14 more
  • Respiratory diseases
  • Nephrology
  • Gastroenterology
  • Hepatology
  • Dermatology
  • Asthma
  • Hematology
  • Cardiology
  • Orthopedics
  • Rheumatology
  • Urology
  • Vaccinology
  • Diabetes and metabolism
  • Virology

Instruments and platforms

  • eCRF

Modalities and species

Modalities
Small molecule
Species and models
  • Healthy volunteers
  • Patients
  • Specialist populations
  • GLP-compliant CROs

Certifications

As the company states them, with the certificate or registry record where there is one.

  • ISO 9001:2015Self-reported

  • GLPSelf-reported

Industries served

  • Biotech
  • Pharmaceutical
  • Medical device
  • Combination product

Company

Type
CRO
Founded
1997
Quality
ISO 9001:2015 · GCLP Accreditation · FDA Letter 2024 · FDA NAI Letters 2020 · FDA NAI Letters 2007

Locations

Based in
Sofia, Bulgaria
Sites
  • Paris, France
  • London, UK
Serves
Europe, Central and Eastern Europe, 24 countries covered

Similar labs